Correlation Between New Residential and Pfizer
Can any of the company-specific risk be diversified away by investing in both New Residential and Pfizer at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining New Residential and Pfizer into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between New Residential Investment and Pfizer Inc, you can compare the effects of market volatilities on New Residential and Pfizer and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in New Residential with a short position of Pfizer. Check out your portfolio center. Please also check ongoing floating volatility patterns of New Residential and Pfizer.
Diversification Opportunities for New Residential and Pfizer
-0.14 | Correlation Coefficient |
Good diversification
The 3 months correlation between New and Pfizer is -0.14. Overlapping area represents the amount of risk that can be diversified away by holding New Residential Investment and Pfizer Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pfizer Inc and New Residential is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on New Residential Investment are associated (or correlated) with Pfizer. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pfizer Inc has no effect on the direction of New Residential i.e., New Residential and Pfizer go up and down completely randomly.
Pair Corralation between New Residential and Pfizer
Assuming the 90 days trading horizon New Residential Investment is expected to generate 0.72 times more return on investment than Pfizer. However, New Residential Investment is 1.39 times less risky than Pfizer. It trades about 0.19 of its potential returns per unit of risk. Pfizer Inc is currently generating about -0.02 per unit of risk. If you would invest 946.00 in New Residential Investment on October 25, 2024 and sell it today you would earn a total of 130.00 from holding New Residential Investment or generate 13.74% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
New Residential Investment vs. Pfizer Inc
Performance |
Timeline |
New Residential Inve |
Pfizer Inc |
New Residential and Pfizer Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with New Residential and Pfizer
The main advantage of trading using opposite New Residential and Pfizer positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if New Residential position performs unexpectedly, Pfizer can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pfizer will offset losses from the drop in Pfizer's long position.New Residential vs. PLAYTIKA HOLDING DL 01 | New Residential vs. Ameriprise Financial | New Residential vs. Playtech plc | New Residential vs. PLAYWAY SA ZY 10 |
Pfizer vs. CLEAN ENERGY FUELS | Pfizer vs. SOFI TECHNOLOGIES | Pfizer vs. AAC TECHNOLOGHLDGADR | Pfizer vs. Carnegie Clean Energy |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Other Complementary Tools
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |